Stockscreener 앱 받기
23.11
0.94%
-0.22
시장 영업 전:
23.16
0.05
+0.22%
Immunome Inc 주식(IMNM)의 최신 뉴스
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
Why (IMNM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Immunome (IMNM) and Resmed (RMD) - The Globe and Mail
Lake Street Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Universal Beteiligungs und Servicegesellschaft mbH Acquires New Position in Immunome, Inc. $IMNM - MarketBeat
Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors - BioSpace
Immunome (IMNM) Submits NDA for Varegacestat to Treat Desmoid Tu - GuruFocus
Craig-Hallum Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $36 - Moomoo
Immunome submits drug application for desmoid tumor treatment - Investing.com
Immunome submits drug application for desmoid tumor treatment By Investing.com - Investing.com South Africa
Immunome (IMNM) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Why is IMNM stock rising today? - MSN
Immunome prices $400M stock offering at $21.50 a share - MSN
The Bull Case For Immunome (IMNM) Could Change Following Varegacestat’s ASCO 2026 Spotlight And NDA Timeline – Learn Why - simplywall.st
A Look At Immunome (IMNM) Valuation As Varegacestat Nears ASCO 2026 Spotlight And FDA NDA Filing - Yahoo Finance
[ARS] Immunome Inc. SEC Filing - Stock Titan
Immunome (IMNM) 2026 proxy: trial success, executive pay and key stockholder votes - Stock Titan
Immunome Desmoid Tumor Data And NDA Plan Test Growth Expectations - simplywall.st
Immunome (IMNM) Long-Term View | Immunome Inc. 23.8% EPS Miss, No Revenue EstimateMiss Estimates - Cổng thông tin điện tử tỉnh Lào Cai
Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting - BioSpace
Immunome’s desmoid tumor trial data selected for ASCO presentation By Investing.com - Investing.com Australia
Understanding Momentum Shifts in (IMNM) - Stock Traders Daily
Immunome’s desmoid tumor trial data selected for ASCO presentation - Investing.com
Immunome (IMNM) Stock: Buy, Sell, Hold? (Market Focus) 2026-04-20Pre Earnings - Cổng thông tin điện tử Tỉnh Sơn La
Is institutional money buying Immunome (IMNM) stock (+5.89%) 2026-04-18Certified Trade Ideas - UBND thành phố Hải Phòng
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Immunome (IMNM) and Eli Lilly & Co (LLY) - The Globe and Mail
Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33 - 富途牛牛
Immunome, Inc. (IMNM) Stock Analysis: Exploring a 52.79% Potential Upside with Strong Buy Consensus - DirectorsTalk Interviews
IMNM News | IMMUNOME INC (NASDAQ:IMNM) - ChartMill
JPMorgan Chase & Co. Cuts Stock Holdings in Immunome, Inc. $IMNM - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Immunome (IMNM) Price Forecast: Breakout Points to Higher Highs Ahead - FXEmpire
Death Cross: Can Immunome Inc be the next market leader2026 Technicals & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Stock Analysis: Is Immunome Inc part of any ETF2026 Retail Activity & Daily Volume Surge Signals - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (IMNM) Movement - Stock Traders Daily
Death Cross: Is Immunome Inc gaining market share2026 Key Lessons & Technical Pattern Based Buy Signals - baoquankhu1.vn
LifeSci Capital Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Is Immunome (IMNM) Stock Expanding | Price at $22.19, Up 1.60%Bullish Pattern - Xã Thanh Hà
Immunome CSO Sells Shares: Transaction Details & Company SnapshotNews and Statistics - IndexBox
Immunome (IMNM) Is Up 11.4% After CEO Share Buy And Positive Phase III DataWhat's Changed - Sahm
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - AOL.com
Insider Sell: What is the long term forecast for Immunome Inc stockDividend Hike & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - The Motley Fool
A Look At Immunome (IMNM) Valuation After Oncology Progress EPS Upgrades And CEO Insider Buying - Sahm
Immunome, Inc. (IMNM) stock price, news, quote and history - Yahoo Finance Singapore
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock By Investing.com - Investing.com South Africa
Immunome CFO Rosett sells $1.4m in shares By Investing.com - Investing.com Canada
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock - Investing.com
0.14%
0.48%
자본화:
|
볼륨(24시간):